MedPath

A random, multi-center controlled trial for Qi-Jing Hui-Xin Decoction in the treatment of microvascular angina

Phase 1
Conditions
microvascular angina
Registration Number
ITMCTR1900002719
Lead Sponsor
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Aged 18 years old;
2. It conforms to the diagnostic criteria of smicrovascular angina (CSS angina severity grade I-III);
3. Those who accord with traditional Chinese medical syndrome meet the above TCM syndrome differentiation;
4. Sign informed consent and be Willing to accept Chinese medicine treatment.

Exclusion Criteria

1. severe heart disease (unstable angina, severe arrhythmia, etc.), Chest pain caused by diseases other than coronary artery disease, such as psychosis, severe neurosis, hyperthyroidism, biliary heart syndrome, gastroesophageal reflux, aortic dissection, etc.;
2. Complicated with uncontrolled grade III hypertension (systolic blood pressure (> 180 mmHg) and/or diastolic blood pressure (> 110 mmHg), severe cardiopulmonary dysfunctionsevere arrhythmia;
3. The patients with liver, kidney, hematopoietic system and other serious diseases, and other serious primary disease;
4. Those who participated in other drug clinical trials within one month;
5. Recently (over 4 weeks) who have undergone major surgery;
6. Pregnancy, lactating women or pregnant planners;
7. Anaphylaxis or allergic to the test drug ingredients1.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The effect of angina pectoris;Improvement of TCM syndromes;
Secondary Outcome Measures
NameTimeMethod
echocardiographic diagnosis;serum lipid level;Seattle Angina Scale score;EKG efficacy;
© Copyright 2025. All Rights Reserved by MedPath